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Angiomyofibroblastoma is a rare tumor of the female
genital tract. This vulvar tumor was first described by
Fletcher et al in 1992 [1] as a mesenchymal neoplasm
that is characteristically composed of blood vessels and
stromal cells. It predominantly occurs in middle-aged
women [2]. These tumors are usually found in the female
genital tract, including the vulva, urethra, vagina and
fallopian tubes [3–5]. Men are affected less frequently
than women. It may be cured by complete local exci-
sion. Its histologic features distinguish it from aggressive
angiomyxoma and malignant myxoid carcinoma.
Case 1 describes a 54-year-old woman who presented
with a painless mass in the anterior aspect of the right
labia majus. The lesion was noted to had increased 
in size gradually over several years. Her medical history
was significant for hypertension, which was controlled
with antihypertensive medications taken regularly for
several years. An examination of the external genitalia
revealed a mobile, non-tender mass at the superior as-
pect of the labia majora. The mass was rubbery and well
circumscribed (Figure), measuring about 3×3×3 cm.
The tumor was excised and was freed from its interior
attachment. The skin was closed with no difficulty, and
there had been no sign of recurrence. The excised tumor
was yellowish to whitish in color, globular in shape,
devoid of capsule, elastic in consistency, measuring 3.4×
3.6 cm, and weighed 34 g. Pathology revealed a rela-
tively circumscribed tumor with alternating hypocellu-
lar and hypercellular areas, manifested as proliferation
of bland-appearing spindles or round/oval stromal cells
with a tendency to perivascular concentration and promi-
nent, irregular-shaped capillary vessels. Mitotic figures
were absent. Immunohistochemical study showed  that
the stromal cells stained positive for vimentin and
desmin but negative for S-100 protein, smooth muscle
actin, CD34 and cytokeratin. These results indicated
angiomyofibroblastoma.
Case 2 describes a 50-year-old, gravida 5, para 3,
abortus 2, who complained of a painless mass at the
perineal area for 3 years. A pelvic examination disclosed
a soft, 2.5-cm, non-tender swelling in the right labia
majus, assumed to be lipoma. A local excision was per-
formed for the lesion. The tumor was well delineated
with minimal local infiltration. Her postoperative care
was uneventful with no sign of recurrence after a year.
The tumor lesion was similar to that of the first case.
It was whitish to yellowish in color, globular, and elas-
tic. It measured 3.0×2.6 cm and weighed 30 g. It also
shared several microscopic features with Case 1. The
final diagnosis was angiomyofibroblastoma.
Angiomyofibroblastoma is a rare, benign, mesenchy-
mal tumor of the vulva. So far, only 20 cases have been
reported in the English literature [6]. The clinical features
of this neoplasm are in the form of a vulvar mass that
is most often misdiagnosed as a Bartholin gland or
labial cyst, lipoma or hydrocele, etc. [7]. Microscopically,
it consists of spindle cells with monomorphous and
hyperchromatic nuclei and mesenchymal cells that sur-
round small-sized blood vessels within a fibrous to myx-
oid mast cell containing stroma. Occasionally, mature
adipose tissue is present in the lesion, and it is some-
times predominant.
The classification of vulvovaginal mesenchymal tu-
mors and differential diagnosis of such lesions are crucial.
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Figure. (A) The 3×3×3 cm tumor at right labia majora in
Case 1. (B) The tumor after excision. Note the absence of
capsule.
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The Table summarizes the variants of mesenchymal
tumors, both benign and malignant types [2,8]. It is
important to distinguish angiomyofibroblastoma from
other mesenchymal tumors because of the differences
in surgical treatment and clinical course. When interme-
diate or malignant tumors like angiomyxoma are diag-
nosed, more aggressive surgical approaches to treatment
are required.
According to Horiguchi et al [9], a high mobility
group protein I-C (HMGI-C) could be expressed in
angiomyofibroblastoma. Meanwhile, basic fibroblast
growth factor and stem cell factor may be related to
vascularity and stromal–mast-cell infiltration. HMGI-
C may be involved in the tumorigenesis of angiomyo-
fibroblastoma [9].
Although rare, angiomyofibroblastoma should be
considered during differential diagnosis of vulvar masses,
especially in the vulvovaginal region. Differentiation from
the more aggressive angiomyxoma is helpful for assessing
recurrence risk.
The intermediate filaments, vimentin and desmin,
have been recommended as useful markers to distin-
guish angiomyofibroblastoma from the aggressive an-
giomyxoma via immunohistochemistry [1]. A thorough
evaluation of mesenchymal tumors such as angiomyofi-
broblastoma should be done whenever possible, because
it may be mimicked by the aggressive angiomyxoma.
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Table. Variants of mesenchymal tumors
Benign tumor Intermediate tumor Malignant tumor
Angiomyofibroblastoma Aggressive angiomyxoma Myxoid carcinoma
Superficial angiomyxoma Atypical lipomatous tumor Myxoid embryonal rhabdomyosarcoma
Cellular angiofibroma Pelvic fibromatosis Myxoid liposarcoma
Fibroepithelial stromal polyp Dermatofibrosarcoma protuberans Myxoid leiomyosarcoma
